LAG3 and neoplasm: Increasing evidence reveals a tumor cell-intrinsic expression of immune receptors, including the CD28 family member CTLA-4 as well as other checkpoint receptors like LAG3, TIGIT, and PD-1 in various malignancies [22, 35, 36, 47, 48].